GAO releases report on rapidly rising drug prices

Yesterday, we told you about a Government Accountability Office report on rising drug prices. Today, there's more on that report, showing that prices for hundreds of brand-name drugs have soared since the beginning of the decade, especially those that treat depression, infections and heart disease. Report

Suggested Articles

WuXi AppTec has appointed Celgene CAR-T program veteran David Chang to lead its cell and gene therapy CDMO, WuXi Advanced Therapies.

Maryland-based Emergent BioSolutions has won a $628 million contract with BARDA to manufacture targeted COVID-19 vaccine hopefuls.

About 76% remdesivir patients had at least one point of clinical improvement on a 7-point scale at day 11, versus 66% of patients on standard care.